Humoral Response to SARS-CoV-2 Vaccine-Boost in Cancer Patients: A Case Series from a Southern European Cancer Center

Humoral Response to SARS-CoV-2 Vaccine-Boost in Cancer Patients: A Case Series from a Southern European Cancer Center

Background: Cancer patients face a greater risk of complications and death after contracting the SARS-CoV-2 virus. Booster doses of the COVID-19 vaccine were suggested to provide additional protection. This study aimed to assess how cancer patients’ immune systems respond to the booster shots and ca...

Full description

Saved in:
Bibliographic Details
Main Authors: Júlio Oliveira, Pedro Cruz, Tânia R. Dias, Mário Sousa-Pimenta, Beatriz Almeida, Bruno Soares, Hugo Sousa, Rui Costa, Carlos Ochoa, Francisca Dias, Rui Medeiros
Format: Article
Language:English
Published: MDPI AG 2024-10-01
Series:Vaccines
Subjects:
SARS-CoV-2
COVID-19
precision medicine
vaccines
humoral immunity
Online Access:https://www.mdpi.com/2076-393X/12/11/1207
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2076-393X/12/11/1207

Similar Items